CClinicalTrials.gg
Sign In
RecruitingNCT06834906Updated Aug 15, 2025

Usability User Testing of the Easy-EyeFM AI Platform

An interventional study of EasyEyeFM-AutoML-AI-platform test and AutoML-EasyEyeFM-AI-platform test in Ocular Diseases, sponsored by Tsinghua University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-08-15.

Sponsored by Tsinghua University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Easy-EyeFM is a code-free artificial intelligence platform designed for ophthalmologists to provide diagnostic and treatment recommendations and help doctors develop customized diagnostic models.

This project aims to evaluate the usability and user-friendliness of the Easy-EyeFM platform for physicians. The study will gather feedback from medical professionals to evaluate the intuitiveness and effectiveness of the platform in supporting model customization and medical image analysis tasks.

Subjects will participate in the trial of the Easy-EyeFM platform and the comparison with the existing commercial platform (AutoML) at the appointed time. The researchers will inform subjects of relevant precautions and assist them to read the user manual before the test. Subjects will complete model customization and picture diagnosis within the prescribed test time, and according to the test results, Score the human-computer interaction experience of the AI platform, fill in the questionnaire, and finally complete the evaluation content.

02

Conditions studied

  • Ocular Diseases
03

In context

Lead sponsor

Tsinghua University is the lead sponsor of 24 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Medical students or doctors
  • Have enough time to participate in this program, about 1 hour continuous assessment
  • Agree to sign the informed consent form

Exclusion criteria

Exclusion Criteria:

  • Poor computer and mobile phone use and reading ability
  • Poor language expression or dialect category is not included in the speech recognition function of the platform
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    group A

    Diagnostic Test: EasyEyeFM-AutoML-AI-platform test

  • Experimental
    group B

    Diagnostic Test: AutoML-EasyEyeFM-AI-platform test

Interventions

  • Diagnostic testEasyEyeFM-AutoML-AI-platform test

    AI platforms using

  • Diagnostic testAutoML-EasyEyeFM-AI-platform test

    AI-platform using

06

What researchers measure

Primary outcomes

  1. System Usability Scale

    Minimum Value: 0 Maximum Value: 100 Higher scores indicate a better outcome, meaning higher system usability.

    Time frame: 1 day

Secondary outcomes

  1. Usage Time

    Time frame: 1 day

  2. Users Assistance Requests Times

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Tsinghua University
    Beijing, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06834906
Lead sponsor
Tsinghua University
Collaborators
First Hospital of Tsinghua University, Beijing Tsinghua Changgeng Hospital, Augenarzt-Praxisgemeinschaft Gutblick AG, Sankara Nethralaya, Department of Medical Services Ministry of Public Health of Thailand, Moorfields Eye Hospital NHS Foundation Trust, Pomeranian Hospitals, Shanghai Health and Medical Center, Hong Kong Eye Hospital, Royal Victoria Eye and Ear Hospital, Hanyang University Guri Hospital, Al-Shifa Trust Eye Hospital, Korle-Bu Teaching Hospital, Accra, Ghana, Nippon Medical School Tama Nagayama Hospital
Responsible party
Tien Yin Wong (Professor, Tsinghua University) — Principal investigator
First posted
Feb 19, 2025
Start date
Jan 26, 2025
Primary completion
Sep 2025 (estimated)
Completion
Sep 2025 (estimated)
Last update
Aug 15, 2025

Study contacts

Jinyuan Wang
Contact
jinyuanwang@tsinghua.edu.cn
086-15801191316
Hongqiu Wang
Contact
hwang007@connect.hkust-gz.edu.cn
Tien Yin Wong
principal investigator · Tsinghua University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Tsinghua University

Start the discussion